301 – 310 of 445
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
(
- Contribution to journal › Article
-
Mark
Body size and risk of differentiated thyroid carcinomas: Findings from the EPIC study
(
- Contribution to journal › Article
-
Mark
Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: Results from the EPIC-EURGAST study
(
- Contribution to journal › Article
-
Mark
Validity of a short questionnaire to assess physical activity in 10 European countries
(
- Contribution to journal › Article
-
Mark
Fiber intake and total and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition cohort
(
- Contribution to journal › Article
-
Mark
Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
(
- Contribution to journal › Article
-
Mark
The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study
(
- Contribution to journal › Article
-
Mark
Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
(
- Contribution to journal › Article
-
Mark
Re: Hepatocellular Carcinoma Risk factors and Disease Burden in a European Cohort: A Nested Case-Control Study Response
(
- Contribution to journal › Letter
-
Mark
The Associations of Advanced Glycation End Products and Its Soluble Receptor with Pancreatic Cancer Risk: A Case-Control Study within the Prospective EPIC Cohort.
2012) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 21(4). p.619-628(
- Contribution to journal › Article